UBS Group’s Moolec Science MLEC Stock Holding History
Bought
Maintained
Sold
Other funds holding MLEC
UBS Group's MLEC Position: Q3 2026 in Review
UBS Group reduced its Moolec Science (MLEC) stake by 81% in Q3 2026, selling an estimated $2.64K and leaving 88 shares worth $429. The position accounts for ﹤0.01% of the portfolio, ranked #10640.
UBS Group first reported a position in MLEC in Q1 2023 and has held it in 10 quarters since. The position peaked at $15.7K in Q3 2024. 4 funds tracked by Wall St. Rank hold MLEC as of Q3 2026.
- UBS Group held 88 shares of Moolec Science worth $429 as of Q3 2026.
- UBS Group sold 382 Moolec Science shares in Q3 2026, an estimated $2.64K.
- Moolec Science made up ﹤0.01% of UBS Group's portfolio in Q3 2026, its #10640 holding.
- UBS Group first reported a position in Moolec Science in Q1 2023 and has held it in 10 quarters since.
- UBS Group's Moolec Science position peaked at $15.7K in Q3 2024.
- 4 funds tracked by Wall St. Rank held Moolec Science as of Q3 2026.
Based on UBS Group's 13F filing for Q3 2026, filed 10 Nov 2026.